Autor(es): Kaida Kenichi

Resumo: Clinical outcome of Guillain-Barré syndrome (GBS) is poorer than may be expected, despite recent applications of plasmapheresis and IVIg. Among prognostic factors of GBS, clinical factors are more useful compared to electrophysiological or biological factors. To improve the outcome of GBS patients with poor prognoses, a worldwide prospective survey (IGOS, International GBS Outcome Study) and a Japanese prospective GBS outcome study (JGOS) have been conducted. These surveys make it possible to define biomarkers for disease activity and recovery, and to develop prognostic models to precisely predict the clinical course and outcome in individual patients in the early stage of the disease.

Palavras-Chave: Barre Guillain-síndrome ; Prognóstico ; DerutaIgG ; Terapia de imunoglobulina intravenosa ;

Imprenta: Brain and Nerve = Shinkei kenkyu? no Shinpo, v. 67, n. 11, p. 1411-1419, 2015

Identificador do objeto digital: 10.11477/mf.1416200313

Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Public health

Data de publicação: 2015

INDICADORES

ACESSO